News

Iconovo taps Lonza for spray-dried obesity biologic Iconovo taps Lonza for spray-dried obesity biologic

Lonza joins the race for weight loss drugs with plans to produce an active pharmaceutical ingredient (API) for Iconovo’s intranasal biologic.

byShreeyashi Ojha, Reporter

Jan 20, 2025

|

1 Min Read

Therapeutic Class

Thermo cites Catalent, capacity, and Trumpian tariffs in positive CDMO outlook Thermo cites Catalent, capacity, and Trumpian tariffs in positive CDMO outlook

byShreeyashi Ojha

Jan 20, 2025

2 Min Read

A US flag juxtaposed with a symbolic representation of the department of commerce

Department of Commerce cracks down on biotechnology exports Department of Commerce cracks down on biotechnology exports

Jan 17, 2025

2 Min Read

A microphone stands at the head of a crowded conference room

Therapeutic Class

Gilead cites manufacturing efficiencies as CAR-T advantage in 2025 Gilead cites manufacturing efficiencies as CAR-T advantage in 2025

Jan 17, 2025

2 Min Read

Samsung Bio lands $1.4bn contract with undisclosed EU client Samsung Bio lands $1.4bn contract with undisclosed EU client

byShreeyashi Ojha

Jan 16, 2025

2 Min Read

A person holds a magnifying glass over stylized representation of DNA

Therapeutic Class

Casgevy and beyond: Allogeneic therapies take spotlight for CRISPR Therapeutics Casgevy and beyond: Allogeneic therapies take spotlight for CRISPR Therapeutics

Jan 15, 2025

2 Min Read

Image of two researchers looking into microscopes

Facilities & Capacity

Aragen $100m PE boost to bolster CDMO ambition in India and beyond

Aragen $100m PE boost to bolster CDMO ambition in India and beyond

byDan Stanton, Editorial director

Facilities & Capacity

Lilly expands India footprint with Hyderabad plant

Lilly expands India footprint with Hyderabad plant

byShreeyashi Ojha, Reporter

Boehringer bolsters ADC biz with $1.3bn Synaffix deal

Boehringer bolsters ADC biz with $1.3bn Synaffix deal

byShreeyashi Ojha, Reporter

laboratory equipment

Samsung Bio extends ADC partnership with LigaChem

Samsung Bio extends ADC partnership with LigaChem

byJosh Abbott, Editor, BioProcess Insider

Image shows an outsourcing sign

Contract catch-up: The latest cross-modality CDMO deals

Contract catch-up: The latest cross-modality CDMO deals

byDan Stanton, Editorial director

Image of two jigsaw puzzle pieces fitting together

Roche buys Poseida in $1.5bn acquisition

Roche buys Poseida in $1.5bn acquisition

byJosh Abbott, Editor, BioProcess Insider

Image of red blood cells

Therapeutic Class

Coagulation of experts: Blood industry bonds together to solidify CGT manufacturing

Coagulation of experts: Blood industry bonds together to solidify CGT manufacturing

byJosh Abbott, Editor, BioProcess Insider

Image of a letter being handwritten

Facilities & Capacity

Moderna eyes mRNA manufacturing efficiencies as 3 plants set to come online in 2025

Moderna eyes mRNA manufacturing efficiencies as 3 plants set to come online in 2025

byJosh Abbott, Editor, BioProcess Insider

Image shows a hand holding a syringe in front of an Irish flag, representing a vaccine manufacturing plant in Ireland

Facilities & Capacity

Merck & Co. buying own dedicated WuXi Vaccine plant for $500m+

Merck & Co. buying own dedicated WuXi Vaccine plant for $500m+

byDan Stanton, Editorial director

WuXi selling cell therapy unit as BIOSECURE continues to play out

WuXi selling cell therapy unit as BIOSECURE continues to play out

byDan Stanton, Editorial director

Facilities & Capacity

Insider’s wrapped: BIOSECURE, AI, CDMO shakeups shaped 2024

Insider’s wrapped: BIOSECURE, AI, CDMO shakeups shaped 2024

byShreeyashi Ojha, Reporter

SK pharmteco secures $1.4bn GLP-1 deal

SK pharmteco secures $1.4bn GLP-1 deal

byShreeyashi Ojha, Reporter

MilliporeSigma to acquire Netherlands-based organoid pioneer HUB

MilliporeSigma to acquire Netherlands-based organoid pioneer HUB

byJosh Abbott, Editor, BioProcess Insider

Facilities & Capacity

Israeli biomanufacturer Scinai expands into US with CDMO subsidiary

Israeli biomanufacturer Scinai expands into US with CDMO subsidiary

byJosh Abbott, Editor, BioProcess Insider

Therapeutic Class

CGT Catapult and UCL to develop digital twin for CAR-T manufacturing

CGT Catapult and UCL to develop digital twin for CAR-T manufacturing

byJosh Abbott, Editor, BioProcess Insider

Novo Catalent deal clears regulatory hurdles

Novo Catalent deal clears regulatory hurdles

byShreeyashi Ojha, Reporter

Facilities & Capacity

Lonza calls time on capsules as mAbs and CGT drive core CDMO strategy

Lonza calls time on capsules as mAbs and CGT drive core CDMO strategy

byDan Stanton, Editorial director

Asahi strengthens autoimmune focus with Chiome partnership

Asahi strengthens autoimmune focus with Chiome partnership

byShreeyashi Ojha, Reporter

Facilities & Capacity

Ins & Outs: Resilience, AGC, Sartorius ride the CEO carousel

Ins & Outs: Resilience, AGC, Sartorius ride the CEO carousel

byShreeyashi Ojha, Reporter

Facilities & Capacity

Diabetes drug firms Sanofi, Novo expand global footprint

Diabetes drug firms Sanofi, Novo expand global footprint

byShreeyashi Ojha, Reporter

Facilities & Capacity

BioMarin bolsters Ireland footprint with $63m expansion

BioMarin bolsters Ireland footprint with $63m expansion

byShreeyashi Ojha, Reporter

Indonesia pledges $30m to Gavi to support global vaccinations

Indonesia pledges $30m to Gavi to support global vaccinations

byJosh Abbott, Editor, BioProcess Insider

WuXi Apptec and WuXi Biologics shares surge as BIOSECURE stumbles

WuXi Apptec and WuXi Biologics shares surge as BIOSECURE stumbles

byJosh Abbott, Editor, BioProcess Insider

Facilities & Capacity

Q&A: Robust supply chains and global networks are among key considerations when choosing an mRNA CDMO

Q&A: Robust supply chains and global networks are among key considerations when choosing an mRNA CDMO

byJosh Abbott, Editor, BioProcess Insider

Therapeutic Class

Is India reliable? Addressing challenges in the pharma industry

Is India reliable? Addressing challenges in the pharma industry

byShreeyashi Ojha, Reporter

Facilities & Capacity

Lilly announces $3bn expansion to injectable drug manufacturing facility

Lilly announces $3bn expansion to injectable drug manufacturing facility

byJosh Abbott, Editor, BioProcess Insider

Facilities & Capacity

Amgen announces $1bn manufacturing expansion in Holly Springs

Amgen announces $1bn manufacturing expansion in Holly Springs

byJosh Abbott, Editor, BioProcess Insider

Facilities & Capacity

Novo expands EU footprint with $200m Novavax plant

Novo expands EU footprint with $200m Novavax plant

byShreeyashi Ojha, Reporter

Therapeutic Class

India’s pharma future relies on regulatory strength

India’s pharma future relies on regulatory strength

byShreeyashi Ojha, Reporter

Subscribe to receive our monthly print or digital publication

Join our 70,000+ readers. And yes, it's completely free.